Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-17,480
Closed -$830K 476
2016
Q2
$830K Buy
17,480
+8,660
+98% +$409K 0.04% 344
2016
Q1
$391K Sell
8,820
-14,615
-62% -$620K 0.01% 387
2015
Q4
$1.12M Buy
+23,435
New +$1.06M 0.03% 321
2015
Q3
Sell
-37,967
Closed -$1.83M 449
2015
Q2
$1.83M Sell
37,967
-144,043
-79% -$6.88M 0.04% 314
2015
Q1
$8.43M Buy
+182,010
New +$8.21M 0.15% 154
2014
Q4
Sell
-254,270
Closed -$9.39M 510
2014
Q3
$9.39M Buy
254,270
+15,210
+6% +$521K 0.07% 259
2014
Q2
$7.71M Sell
239,060
-33,423
-12% -$1.03M 0.05% 311
2014
Q1
$7.89M Buy
272,483
+72,130
+36% +$2.2M 0.06% 271
2013
Q4
$6.55M Sell
200,353
-9,930
-5% -$317K 0.05% 312
2013
Q3
$6.54M Buy
210,283
+43,373
+26% +$1.33M 0.07% 271
2013
Q2
$5.16M Buy
+166,910
New +$5.4M 0.07% 290

Other funds holding ZTS

Euclid Advisors's ZTS Position: Q3 2016 in Review

Euclid Advisors sold out of Zoetis (ZTS) in Q3 2016, closing a stake of 17,480 shares — an estimated $830K sold.

Euclid Advisors first reported a position in ZTS in Q2 2013 and held it in 11 quarters. The position peaked at $9.39M in Q3 2014. 653 funds tracked by Wall St. Rank hold ZTS as of Q3 2016.

  • Euclid Advisors reported no remaining Zoetis position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 17,480 Zoetis shares in Q3 2016, an estimated $830K.
  • Euclid Advisors first reported a position in Zoetis in Q2 2013 and held it in 11 quarters.
  • Euclid Advisors's Zoetis position peaked at $9.39M in Q3 2014.
  • 653 funds tracked by Wall St. Rank held Zoetis as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.